Composition, form of production and packaging
? Spray for topical application in the form of a colorless transparent solution with a weak characteristic sea smell.
sterile hypertonic solution of Adriatic Sea water with natural salts and microelements (100%) including:
Na + not less than 7500 mg / l
K + not less than 200 mg / l
Ca 2+ not less than 250 mg / l
Mg 2+ not less than 1000 mg / l
Cl - not less than 16500 mg / l
SO 4 2- not less than 1800 mg / l
HCO 3 - not less than 100 mg / l
Br - not less than 40 mg / l
30 ml - bottles of dark glass (1) with a spray device - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2013.
The drug is based on a hypertonic sterile solution of sea water. It is used with a therapeutic and preventive purpose for cleansing, removing irritation and protecting the mucous membrane of the pharynx and larynx.
Microelements included in the drug, increase the resistance of the mucous membrane of the pharynx to pathogenic bacteria and viruses, promote local immunity.
Data on the pharmacokinetics of Aqua Maris is not available.
- for prophylaxis and in the complex treatment of acute and chronic infectious and inflammatory diseases of the pharynx and larynx (tonsillitis, adenoiditis, pharyngitis, laryngitis);
- for prophylaxis and in complex treatment of ARVI (including during pregnancy and lactation);
- dryness of the mucous membrane of the posterior pharyngeal wall due to increased dryness (central heating, conditioning) or air pollution - in order to preserve the physiological characteristics of the pharyngeal mucosa in altered microclimatic conditions.
Adults and children are prescribed 4-6 times / day for 3-4 injections, directing the nebulizer to the back wall of the pharynx.
Turn sprayer horizontally before use. When using for the first time, press the cover several times.
Possible: allergic reactions.
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
It is possible to use the drug Aqua Maris during pregnancy and lactation (breastfeeding) according to the indications.
APPLICATION FOR CHILDREN
It is possible to use according to the indications according to the dosing regimen.
The drug does not have systemic effects on the body.
Possible application with other drugs used to treat inflammatory diseases of the pharynx and larynx.
To date, no cases of an overdose of Aqua Maris have been reported.
Drug interaction of the drug Aqua Maris was not observed.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of the reach of children at a temperature of no higher than 25 В° C. Shelf life - 3 years.